Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
3 followers
Gilead Sciences
173 followers
Regeneron
144 followers
Illumina
82 followers
Agilent Technologies
89 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
50 followers
Explore companies